The article mentions the two options going forward as DCVax and TTF, however TTF isn’t deemed cost effective by NICE according to how I read the article. DcvaxL hasn’t reached the point of NICE recommendation but should be upcoming and then hopefully approved in the UK, and then available under their health system and payments.
For this young man every month is so important and hence the crowdfunding approach to pay for DCVax under specials/compassionate means.
Market Data 
Markets 
